UPenn Scientists, Regeneron Developing Nasal Spray to Prevent COVID-19 Infections
FDA Grants Emergency Use Approval for Regeneron COVID-19 Treatment, But There's a Catch
Regeneron Stops Trial of Antibody Drug for Severely Ill COVID-19 Patients
Regeneron CEO Says US Gov't Secured 300k Doses With $450 Million Contract
Most Read